Contact
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
The Pharmaceuticals market in Benelux has been experiencing significant growth in recent years.
Customer preferences: One of the main customer preferences in the Benelux region is for high-quality pharmaceutical products that are affordable and easily accessible. Customers in the region are also increasingly interested in natural and organic products, which has led to a rise in demand for alternative medicines.
Trends in the market: One of the key trends in the Pharmaceuticals market in Benelux is the increasing popularity of generic drugs. This is due to the fact that generic drugs are often significantly cheaper than their branded counterparts, and are therefore more accessible to a wider range of customers. Another trend in the market is the growing demand for personalized medicine, which involves the use of genetic information to tailor treatments to individual patients.
Local special circumstances: The Benelux region has a highly developed healthcare system, with a strong emphasis on preventative care and early intervention. This has led to a high level of demand for pharmaceutical products, as well as a focus on research and development in the sector. Additionally, the region has a highly educated population, which is increasingly interested in taking control of their own health and wellbeing.
Underlying macroeconomic factors: One of the key macroeconomic factors driving the growth of the Pharmaceuticals market in Benelux is the aging population. As the population ages, there is a greater need for pharmaceutical products to treat age-related conditions such as arthritis, dementia, and cardiovascular disease. Additionally, the region has a strong economy and a high standard of living, which means that customers are willing to pay a premium for high-quality pharmaceutical products. Finally, the Benelux region is home to a large number of pharmaceutical companies, which has led to a highly competitive market and a focus on innovation and quality.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)